On December 8, 2023, the news broke that no FC Barcelona fan wanted to hear. Mapi León was seriously injured in training and injured her meniscus. The Barça center-back, who had to undergo surgery, ...

NESS ZIONA, Israel, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on developing innovative long-acting ...

GA Depot is a long-acting injection version of the approved Glatiramer Acetate (GA, commercially available as Copaxone ® /Glatopa ® ). PPMS is characterized by continued worsening neurologic function ...

Mapi León, the last of ‘Las 15’ players who refused to play for the Spanish women’s national team in 2022 has returned to the fold this week after a three year absence. León last represented her ...

Exciting news for FC Barcelona just a few hours before the Champions League final against Olympique Lyon. The Barça club shared that Mapi León, who has been out since December due to an injury to the ...

Mapi Pharma has closed a $10 million (€9 million) Series A round to finance mid-phase trials of its once-a-month version of Teva's ($TEVA) blockbuster multiple ...

Viatris likely just lost one of its top product debuts for 2024, thanks to an FDA rejection of its partner Mapi Pharma’s application for a new version of Teva’s multiple sclerosis (MS) drug Copaxone.

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that ...